🔎 Trials Near Me

Utama › Dermatitis Atopik (Eksim) › Massachusetts

Kajian klinikal Dermatitis Atopik (Eksim) di Massachusetts

6 kajian untuk Dermatitis Atopik (Eksim) sedang mencari peserta di lokasi di Massachusetts.

Bandar di Massachusetts

Teks kajian rasmi (Bahasa Inggeris)

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  • Novartis Investigative Site, Brighton
Mengambil pesertaFasa 2
Umur 18 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06947993

CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness

  • CorEvitas, LLC, Waltham
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT04504955

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

  • Boston Specialists /ID# 265810, Boston
  • Beacon Clinical Research /ID# 263843, Quincy
Mengambil pesertaFasa 3
Umur 18 hingga 63 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT06389136

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

  • CorEvitas, LLC, Waltham
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 10 hingga 15 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT06238765

Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

  • Boston Children's Hospital, Boston
Mengambil pesertaKajian pemerhatian
Umur 6 hingga 65 · Semua jantina · Dikemas kini 18 Mei 2026 · NCT04455906

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

  • Galderma Investigational Site 7065, Brighton
  • Galderma Investigationa Site 7104, Milford
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 13 Mac 2026 · NCT06988605

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.